A pill that could help end the AIDS epidemic, Canada legalizes marijuana, homelessness in New York City public schools, and the largest U.S. government budget deficit in six years.

Here are the top newsworthy items from this past week as shared on our Facebook page.

• Gilead Sciences Inc.’s Truvada pill, taken daily by thousands of men across Sydney and other parts of Australia, led to a globally unprecedented reduction in new HIV cases, showing that a targeted, preventative approach may accelerate progress on ending the AIDS epidemic.

From Bloomberg

• Canada yesterday became the world’s second country (after Uruguay) to legalize recreational marijuana.

The Globe and Mail

• While India has poor infrastructure and a quarter of its population in poverty, the country’s middle class is growing, prompting major investment from retail giants WalMart and Amazon.

From Bloomberg Businessweek

• Homelessness in New York public schools is at a record high with 114,659 Students out of 1.1 million. Tonight, about one out of every 10 students in New York City will sleep in a homeless shelter or in the homes of relatives.

From The New York Times

• President Trump threatened to deploy the military and close the southern border if Mexico doesn’t stop an “onslaught” of Central American migrants from reaching the U.S.

From The Wall Street Journal

• The U.S. government ran its largest budget deficit in six years during the fiscal year that ended last month, an unusual development in a fast-growing economy. The increase was driven in large part by a sharp decline in corporate tax revenues after the Trump tax cuts took effect.

From The Wall Street Journal

• The nations of the Five Eyes alliance—Australia, Britain, Canada, New Zealand and the U.S.—have been exchanging classified information on China’s foreign activities with other like-minded countries such as Germany and Japan since the start of the year.

From The Wall Street Journal

 

Like us on Facebook: The Motley Experience

Follow us on Twitter: @MotleyXperience